Avricore Health (AVCRF) FCF Margin (2009 - 2025)

Avricore Health (AVCRF) has reported FCF Margin for 14 consecutive years, with 873.89% the latest figure, recorded in Q4 2025.

• In Q4 2025, FCF Margin changed N/A year-over-year to 873.89%; the TTM figure through Jun 2026 stood at 419.19% (down 43101.0% YoY), while the FY2025 annual figure was 131.38%, down 15616.0% from the prior year.
• FCF Margin fell to 873.89% in Q4 2025 per AVCRF's latest filing, from 768.2% in the prior quarter.
• Across five years, FCF Margin topped out at 109.67% in Q3 2022 and bottomed at 6204.37% in Q2 2021.
• Historically, FCF Margin has averaged 794.52% across 5 years, with a median of 135.31% in 2022.
• Annual changes were most pronounced in 2021 — FCF Margin plunged 315127 bps — and 2022, when it jumped 606906 bps.
• Avricore Health's FCF Margin stood at 1359.57% in 2021, then surged by 85 bps to 202.79% in 2022, then soared by 122 bps to 43.66% in 2023, then tumbled by 43 bps to 24.78% in 2024, then tumbled by 3627 bps to 873.89% in 2025.
• Business Quant data shows AVCRF's FCF Margin at 873.89% in Q4 2025, 768.2% in Q3 2025, and 1414.72% in Q2 2025.